DOE report identifies fusion diagnostics as missing link for commercial power plants

Artist’s conception depicts advanced fusion diagnostics peering into a glowing plasma core

(Image courtesy of Ariel Davis)

A new U.S. Department of Energy report is calling for a stronger national effort to advance fusion diagnostics, identifying them as a critical gap between today’s experimental devices and the reliable power plants targeted for the 2030s. The instruments measure plasma conditions including temperature, density and magnetic field behaviour, data that determine whether a reactor can operate safely and continuously at commercial scale.

The report grew out of the 2024 Basic Research Needs Workshop on Measurement Innovation, organised under the DOE’s Fusion Energy Sciences program. Luis Delgado-Aparicio of Princeton Plasma Physics Laboratory chaired the study and Sean Regan of the University of Rochester’s Laboratory for Laser Energetics co-chaired it. Around seventy researchers from national laboratories, universities and private fusion companies took part.

Participants reviewed diagnostic requirements across seven plasma regimes, from low-temperature industrial plasmas to the extreme conditions inside inertial confinement fusion systems. They found that current tools consistently fall short of what commercial reactors will require. Components must survive sustained neutron bombardment and electromagnetic interference while resolving events that unfold in under a nanosecond. The group identified machine learning as a potential accelerant for diagnostic design and optimisation.

A central recommendation is the creation of a national network called CalibrationNetUS, modelled on the LaserNetUS program that links U.S. high-energy-density laser facilities. It would coordinate prototype development, establish shared calibration standards and move technology from research institutions to private developers. Workforce training forms part of the proposal.

Private fusion companies have raised more than seven billion dollars since 2020, with several targeting pilot plants in the early 2030s. The DOE’s Fusion Science and Technology Roadmap runs to the mid-2030s and treats diagnostic capability as foundational alongside plasma confinement and materials performance. Delgado-Aparicio said measurement innovations have driven and will continue to drive breakthroughs in plasma science. Regan linked sustained diagnostic investment directly to U.S. leadership in fusion.

The findings are expected to shape federal funding decisions in the coming years and address concerns over China’s advancing fusion programme. Diagnostic technologies developed for fusion also carry applications in materials processing, space propulsion and medical research.

Stay ahead in the fusion revolution explore more breakthroughs from leading innovators in clean energy technology.